132 related articles for article (PubMed ID: 30689515)
21. The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization.
Petre J; Pizza M; Nencioni L; Podda A; De Magistris MT; Rappuoli R
Dev Biol Stand; 1996; 87():125-34. PubMed ID: 8854009
[TBL] [Abstract][Full Text] [Related]
22. Pertussis toxin activates adult and neonatal naive human CD4+ T lymphocytes.
Tonon S; Badran B; Benghiat FS; Goriely S; Flamand V; Willard-Gallo K; Willems F; Goldman M; De Wit D
Eur J Immunol; 2006 Jul; 36(7):1794-804. PubMed ID: 16783847
[TBL] [Abstract][Full Text] [Related]
23. Parenteral immunization of mice with a genetically inactivated pertussis toxin DNA vaccine induces cell-mediated immunity and protection.
Fry SR; Chen AY; Daggard G; Mukkur TKS
J Med Microbiol; 2008 Jan; 57(Pt 1):28-35. PubMed ID: 18065664
[TBL] [Abstract][Full Text] [Related]
24. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28.
Ryan M; McCarthy L; Rappuoli R; Mahon BP; Mills KH
Int Immunol; 1998 May; 10(5):651-62. PubMed ID: 9645613
[TBL] [Abstract][Full Text] [Related]
25.
Rodriguez D; Goulart C; Pagliarone AC; Silva EP; Cunegundes PS; Nascimento IP; Borra RC; Dias WO; Tagliabue A; Boraschi D; Leite LCC
Front Immunol; 2019; 10():1460. PubMed ID: 31297119
[TBL] [Abstract][Full Text] [Related]
26. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
[TBL] [Abstract][Full Text] [Related]
27. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
[TBL] [Abstract][Full Text] [Related]
29. Identification of pertussis-specific effector memory T cells in preschool children.
de Rond L; Schure RM; Öztürk K; Berbers G; Sanders E; van Twillert I; Carollo M; Mascart F; Ausiello CM; van Els CA; Smits K; Buisman AM
Clin Vaccine Immunol; 2015 May; 22(5):561-9. PubMed ID: 25787136
[TBL] [Abstract][Full Text] [Related]
30. Engineering bacterial toxin for the development of new vaccine against pertussis.
Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R
Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870
[TBL] [Abstract][Full Text] [Related]
31. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
[TBL] [Abstract][Full Text] [Related]
32. Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune response.
Rappuoli R; Pizza M; Covacci A; Bartoloni A; Nencioni L; Podda A; De Magistris MT
FEMS Microbiol Immunol; 1992 Oct; 5(4):161-70. PubMed ID: 1384602
[TBL] [Abstract][Full Text] [Related]
33. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.
Agnolon V; Bruno C; Leuzzi R; Galletti B; D'Oro U; Pizza M; Seubert A; O'Hagan DT; Baudner BC
Int J Pharm; 2015 Aug; 492(1-2):169-76. PubMed ID: 26149936
[TBL] [Abstract][Full Text] [Related]
34. Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy.
Lima L; Molina MDGF; Pereira BS; Nadaf MLA; Nadaf MIV; Takano OA; Carneiro-Sampaio M; Palmeira P
Vaccine; 2019 May; 37(19):2569-2579. PubMed ID: 30955978
[TBL] [Abstract][Full Text] [Related]
35. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
[TBL] [Abstract][Full Text] [Related]
36. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.
Auderset F; Ballester M; Mastelic-Gavillet B; Fontannaz P; Chabaud-Riou M; Reveneau N; Garinot M; Mistretta N; Liu Y; Lambert PH; Ochs M; Siegrist CA
Front Immunol; 2019; 10():1520. PubMed ID: 31333656
[TBL] [Abstract][Full Text] [Related]
37. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses.
Mascart F; Verscheure V; Malfroot A; Hainaut M; Piérard D; Temerman S; Peltier A; Debrie AS; Levy J; Del Giudice G; Locht C
J Immunol; 2003 Feb; 170(3):1504-9. PubMed ID: 12538714
[TBL] [Abstract][Full Text] [Related]
38. Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.
van den Berg BM; David S; Beekhuizen H; Mooi FR; van Furth R
Vaccine; 2000 Dec; 19(9-10):1118-28. PubMed ID: 11137247
[TBL] [Abstract][Full Text] [Related]
39. The pertussis problem.
Plotkin SA
Clin Infect Dis; 2014 Mar; 58(6):830-3. PubMed ID: 24363332
[TBL] [Abstract][Full Text] [Related]
40. T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.
Ausiello CM; Lande R; Stefanelli P; Fazio C; Fedele G; Palazzo R; Urbani F; Mastrantonio P
Clin Diagn Lab Immunol; 2003 Jul; 10(4):637-42. PubMed ID: 12853397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
